SYK240719P340000
- 4.70
- -2.89-38.08%
Stryker Corp Newsroom
3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now
Masimo (MASI) Preliminary Q2 Results Aided by Healthcare Unit
Goldman Sachs Adjusts Price Target on Stryker to $364 From $372
Stryker (SYK) has an average outperform rating and a price target range of $242 to $406, according to analysts polled by Capital IQ.
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Stryker (NYSE:SYK) has outperformed the market over the past 10 years by 4.1% on an annualized basis producing an average annual return of 15.02%. Currently, Stryker has a market capitalization of $12
Weekend Reading | How Johnson & Johnson Orthopedics' Empire Dream Was Shattered?
The opportunity for the pharmaceutical industry to explode must be hidden in the unmet clinical needs, which are the directions that pharmaceutical companies need to continue to cultivate.
Three Reasons to Hold BD (BDX) Stock in Your Portfolio Now
Investors Appear Satisfied With Stryker Corporation's (NYSE:SYK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Stryker Corporation (NYSE:SYK) as a stock to avoid entirely with its 37.6x
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Should You Investigate Stryker Corporation (NYSE:SYK) At US$334?
Stryker Is Maintained at Outperform by Evercore ISI Group
Stryker Is Maintained at Outperform by Evercore ISI Group
What 14 Analyst Ratings Have To Say About Stryker
Ratings for Stryker (NYSE:SYK) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offeri
Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $365
Evercore ISI Group analyst Vijay Kumar maintains Stryker with a Outperform and lowers the price target from $370 to $365.
Stryker Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 8.47% Evercore ISI Group $370 → $365 Maintains Outperform 05/30/2024 10.55% Goldman Sachs → $37
Mercy Medical Center First in Mid-Atlantic Region to Offer Orthopedic Patients New Mixed Reality Technology Platform for Shoulder Surgery
Dr. Gregory Gasbarro will be available for a virtual press briefing on Tuesday, July 2, 2024 at 11 AM ET to answer questions from media. Media register here to attend and receive the video and the tr
Evercore Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $365
Evercore analyst Vijay Kumar maintains $Stryker Corp(SYK.US)$ with a buy rating, and adjusts the target price from $370 to $365.According to TipRanks data, the analyst has a success rate of 47.4% and
Evercore ISI Adjusts Price Target on Stryker to $365 From $370, Maintains Outperform Rating
Stryker (SYK) has an average outperform rating and a price target range of $242 to $406, according to analysts polled by Capital IQ. Price: 335.85, Change: -0.65, Percent Change: -0.19
Stryker to Announce Financial Results for Its Second Quarter of Fiscal Year 2024
Portage, Michigan, July 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, July 30, 2024. A press release will be issued
Stryker's (NYSE:SYK) Investors Will Be Pleased With Their Decent 73% Return Over the Last Five Years
Stryker Corp To Go Ex-Dividend On June 28th, 2024 With 0.8 USD Dividend Per Share
June 26th (Eastern Time) - $Stryker Corp(SYK.US)$ is trading ex-dividend on June 28th, 2024.Shareholders of record on June 28th, 2024 will receive 0.8 USD dividend per share on July 31st, 2024. The ex
Top Analyst Reports for NIKE, Stryker & TJX